IFNA4: A Potential Drug Target and Biomarker for Interferon Alpha 4

Target Name: IFNA4

NCBI ID: G3441

IFNA4

IFNA4: A Potential Drug Target and Biomarker for Interferon Alpha 4

Interferon alpha 4 (IFNA4) is a protein that plays a critical role in the regulation of immune responses and inflammation. It is a cytoplasmic protein that is expressed in a variety of tissues, including the liver, spleen, and peripheral blood cells. IFNA4 is involved in the production of different types of interferon, which are proteins that play a central role in the immune response.

One of the functions of IFNA4 is to regulate the production of interferon alpha chain (IFNC), which is a protein that is involved in the production of interleukin-2 (IL-2). IL-2 is a cytokine that plays a critical role in the regulation of immune responses and is involved in the development of various types of cancer. IFNC is produced by the interaction of IFNA4 with the transcription factor colony-stimulating gene (CSG), which is a protein that is responsible for regulating the production of IL -2.

Another function of IFNA4 is to regulate the production of interferon beta chain (IFNB), which is a protein that is involved in the regulation of DNA replication and repair. IFNB is produced by the interaction of IFNA4 with the transcription factor RNA binding protein (RBP ), which is a protein that is responsible for regulating the production of IFNB.

IFNA4 is also involved in the regulation of the production of IFNgamma chain (IFNG), which is a protein that is involved in the regulation of inflammation. IFNG is produced by the interaction of IFNA4 with the transcription factor interleukin-1 receptor alpha chain (IL -1RAP), which is a protein that is responsible for regulating the production of IL-1.

IFNA4 is a protein that is expressed in a variety of tissues and is involved in the regulation of different types of interferon. It is possible that IFNA4 could be a drug target or biomarker for various types of cancer, due to its involvement in the regulation of the production of different types of interferon.

One potential way to target IFNA4 is through the use of small molecules, such as drugs that inhibit the interaction of IFNA4 with CSG or RBP. These drugs could be used to inhibit the production of IFNC, IFNB, or IFNG, which could lead to a decrease in the production of interferon and a reduction in the production of different types of cancer.

Another potential way to target IFNA4 is through the use of antibodies that are specific for IFNA4. These antibodies could be used to detect and measure the level of IFNA4 in different tissues and to monitor the effects of drugs on the production of interferon.

In conclusion, IFNA4 is a protein that is involved in the regulation of different types of interferon and is a potential drug target or biomarker for various types of cancer. Further research is needed to fully understand the role of IFNA4 in the regulation of interferon and to develop effective treatments for cancer.

Protein Name: Interferon Alpha 4

Functions: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase

The "IFNA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFNA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets